Silicon Valley-based venture capital investor Eclipse has picked up $1.3bn across its latest pair of funds, bringing its total assets under management to about $10bn.
Energy-focused private equity major ArcLight Capital Partners has soared past its Fund VIII target to reach a $3.9bn final close, marking its biggest vehicle to date.
EQT Life Sciences has exited its minority stake in Tubulis, a Germany-based clinical-stage biotech company developing next-generation antibody-drug conjugates.
Carmel Partners has closed its ninth multifamily real estate value creation fund on $1.35bn, below the $1.58bn it gathered for its predecessor vehicle in 2023.
KKR has raised about $23bn at the final close of its latest mammoth North America-focused private equity fund, the largest vehicle of its kind focused solely on that continent.